✦ LIBER ✦

Mutation at the catalytic site (M519V) in glycogen storage disease type II (Pompe disease)

✍ Scribed by Maryann L. Huie; Rochelle Hirschhorn; Agnes S. Chen; Frank Martiniuk; Nan Zhong

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 259 KB
Volume: 4
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.1380040410

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinicopathological analysis of the homo

Clinicopathological analysis of the homozygous p.W1327X AGL mutation in glycogen storage disease type 3

✍ Benedikt Schoser; Dieter Gläser; Josef Müller-Höcker 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

Mutation profile of the GAA gene in 40 I

Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II

✍ A.L.E. Montalvo; B. Bembi; M. Donnarumma; M. Filocamo; G. Parenti; M. Rossi; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

Glycogen storage disease type II (GSDII) is a recessively inherited disorder due to the deficiency of acid alpha-glucosidase (GAA) that results in impaired glycogen degradation and its accumulation in the lysosomes. We report here the complete molecular analysis of the GAA gene performed on 40 Itali

Pathological features of glycogen storag

Pathological features of glycogen storage disease type II highlighted in the knockout mouse model

✍ Bijvoet, Agnes G. A.; Van Hirtum, Hans; Vermey, Marcel; Van Leenen, Dik; Van der 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

Glycogen storage disease type II (GSDII; Pompe's disease) is an autosomal recessive disease caused by lysosomal -glucosidase deficiency. Skeletal muscle weakness is the most conspicuous clinical symptom of patients suffering from GSDII and skeletal muscle also is prominently involved in the knockout

Novel mutation (G188R) in the G6Pase gen

Novel mutation (G188R) in the G6Pase gene of a patient with glycogen storage disease type 1a

✍ Pascale Trioche; Philippe Labrune; Michel Odièvre; Michelle Hedchouel; Jean-Fran 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

Germline mutations in the BRCAl gene confer susceptibility to hereditary breast and ovarian cancer (Easton et al., 1993; Ford et al., 1994). We report a new mutation in the BRCAl gene in an Austrian hereditary breast and ovarian cancer (HBOC) family with four breast cancer cases and one ovarian canc

Twenty-two novel mutations in the lysoso

Twenty-two novel mutations in the lysosomal α-glucosidase gene (GAA) underscore the genotype–phenotype correlation in glycogen storage disease type II

✍ Monique M.P. Hermans; Dik van Leenen; Marian A. Kroos; Clare E. Beesley; Ans T. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views

## Communicated by Elizabeth Neufeld Patients with glycogen storage disease type II (GSDII, Pompe disease) suffer from progressive muscle weakness due to acid a-glucosidase deficiency. The disease is inherited as an autosomal recessive trait with a spectrum of clinical phenotypes. We have investiga

Two mutations affecting the transport an

Two mutations affecting the transport and maturation of lysosomal α-glucosidase in an adult case of glycogen storage disease type II

✍ Monique M. P. Hermans; Marian A. Kroos; Esther De Graaff; Ben A. Oostra; Arnold 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

The autosomal recessive glycogen storage disease type I1 is associated with a deficiency of lysosomal a-glucosidase (acid maltase). This paper reports on the mutations in the lysosomal a-glucosidase alleles of an adult patient. A G-1927 to A transition was discovered in exon 14 causing the substitut